Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H18N2O6 |
| Molecular Weight | 334.3239 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(ON1C(=O)CCC1=O)[C@H]2CC[C@H](CN3C(=O)C=CC3=O)CC2
InChI
InChIKey=JJAHTWIKCUJRDK-XYPYZODXSA-N
InChI=1S/C16H18N2O6/c19-12-5-6-13(20)17(12)9-10-1-3-11(4-2-10)16(23)24-18-14(21)7-8-15(18)22/h5-6,10-11H,1-4,7-9H2/t10-,11-
| Molecular Formula | C16H18N2O6 |
| Molecular Weight | 334.3239 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC), an N-hydroxysuccinimide ester derived from 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid, is a non-cleavable and membrane permeable crosslinker. It is used for enzyme labelling of antibodies - both enzyme and antibody specificity can be preserved; for creation of specific bioconjugates via one- or two-step crosslinking reactions; for creation of sulfhydryl-reactive, maleimide-activated carrier proteins for coupling haptens. SMCC conjugation occurs via a maleimide group that is sulfhydryl (thiol; -SH) reactive and a NHS ester group that is amine reactive and forms stable, covalent protein crosslinks. SMCC crosslinker must be dissolved in an organic solvent, such as DMSO or DMF, and then can be added to an aqueous crosslinking reaction. SMCC crosslinking reagent is permeable across the lipid bilayer of the cell membrane and can be used to crosslink intracellular proteins and peptides.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Novel trastuzumab-DM1 conjugate: Synthesis and bio-evaluation. | 2019-08 |
|
| Impacts of Cross-Linkers on Biological Effects of Mesoporous Silica Nanoparticles. | 2017-03-22 |
|
| Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines. | 2015 |
|
| Trastuzumab emtansine: first global approval. | 2013-05 |
|
| Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates. | 1989-06-02 |
|
| Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma. | 1988-09-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:15:24 GMT 2025
by
admin
on
Mon Mar 31 19:15:24 GMT 2025
|
| Record UNII |
B357P1G1IF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
B357P1G1IF
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
344483
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
DTXSID30215307
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
63174
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
B357P1G1IF
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY | |||
|
64987-85-5
Created by
admin on Mon Mar 31 19:15:24 GMT 2025 , Edited by admin on Mon Mar 31 19:15:24 GMT 2025
|
PRIMARY |